Serum steroids in relation to prostate cancer risk in a case-control study (Greece)

Cancer Causes Control. 1997 Jul;8(4):632-6. doi: 10.1023/a:1018454632045.

Abstract

Blood samples were collected from 52 incident cases of histologically confirmed prostate cancer and 52 age- and town of residence-matched healthy controls in Athens, Greece. Samples were analyzed blindly in Boston, Massachusetts (USA) for testosterone (T), estradiol (E2), sex hormone-binding globulin (SHBG), and dihydrotestosterone (DHT). The data were modeled using multiple logistic regression with adjustment for age, height, body mass index (wt/ht2), years of schooling, and mutually among hormones. DHT was associated inversely, significantly, and strongly with the risk of prostate cancer, whereas T was associated marginally positively, and E2 was associated nonsignificantly inversely with the disease. No association was observed in this study with respect to SHBG.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Aged
  • Case-Control Studies
  • Dihydrotestosterone / blood*
  • Estradiol / blood*
  • Humans
  • Logistic Models
  • Male
  • Odds Ratio
  • Prostatic Neoplasms / etiology*
  • Prostatic Neoplasms / pathology
  • Residence Characteristics
  • Risk Factors
  • Sex Hormone-Binding Globulin / metabolism*
  • Testosterone / blood*
  • Urban Health

Substances

  • Sex Hormone-Binding Globulin
  • Dihydrotestosterone
  • Testosterone
  • Estradiol